Cargando…
Management of cytotoxic chemotherapy-induced hand-foot syndrome
Improvements in systemic cancer treatments have resulted in more patients surviving for prolonged periods of time on treatment. This has made treatment-related toxicity and quality of life concerns increasingly relevant. Hand-foot syndrome (HFS) is a common skin reaction to systemic therapy that sho...
Autores principales: | Kwakman, Johannes J.M., Elshot, Yannick S., Punt, Cornelis J.A., Koopman, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232019/ https://www.ncbi.nlm.nih.gov/pubmed/32431787 http://dx.doi.org/10.4081/oncol.2020.442 |
Ejemplares similares
-
Gemcitabine and Docetaxel Combination Chemotherapy Induced Dermatomyositis Associated with Hand-Foot Syndrome
por: Kawada, Mayuko, et al.
Publicado: (2021) -
Pazopanib induced hand-foot syndrome
por: Sundriyal, Deepak, et al.
Publicado: (2015) -
Hand–foot syndrome induced by chemotherapy drug: Case series study and literature review
por: Zaiem, Ahmed, et al.
Publicado: (2022) -
Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer
por: Punt, C.J.A., et al.
Publicado: (2023) -
Compliance and Effective Management of the Hand-Foot Syndrome in Colon Cancer Patients Receiving Capecitabine as Adjuvant Chemotherapy
por: Son, Hyun-Sook, et al.
Publicado: (2009)